Academic Commons

Articles

Plasma Amyloid Beta-Peptide 1-42 and Incipient Alzheimer's Disease

Mayeux, Richard Paul; Tang, Mingxin; Jacobs, Diane; Manly, Jennifer J.; Bell, Karen L.; Merchant, Carol; Small, Scott A.; Stern, Yaakov; Wisniewski, Henry M.; Mehta, Pankaj D.

Mutations in the amyloid precursor protein and presenilin 1 and 2 genes result in elevated plasma levels of the amyloid beta-peptide species terminating at amino acid residue 42 (A beta1-42). In a longitudinal study of unrelated elderly individuals, those who subsequently developed Alzheimer's disease had higher plasma levels of A beta1-42 at entry than did those who remained free of dementia. The results indicate that elevated plasma levels of the released A beta peptide A beta1-42 may be detected several years before the onset of symptoms, supporting that extracellular A beta1-42 plays an important role in the pathogenesis of late-onset Alzheimer's disease.

Files

  • thumnail for Mayeux-1999-Plasma amyloid beta-peptide 1-42 a.pdf Mayeux-1999-Plasma amyloid beta-peptide 1-42 a.pdf application/pdf 7.15 MB Download File

Also Published In

More About This Work

Academic Units
Neurology
Published Here
February 23, 2018
Academic Commons provides global access to research and scholarship produced at Columbia University, Barnard College, Teachers College, Union Theological Seminary and Jewish Theological Seminary. Academic Commons is managed by the Columbia University Libraries.